Angde Biotech Pharmaceutical Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Angde Biotech Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . (NCT05629598) | Angde Biotech Pharmaceutical Co., Ltd. | 2022-04-13 |
| A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE） (NCT05295173) | Angde Biotech Pharmaceutical Co., Ltd. | 2022-03-21 |
| Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA) (NCT04110275) | Angde Biotech Pharmaceutical Co., Ltd. | 2019-10-01 |
| A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke. (NCT04028518) | Angde Biotech Pharmaceutical Co., Ltd. | 2019-07-20 |
Track Angde Biotech Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.